Autism biomarkers: challenges, pitfalls and possibilities

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with heterogeneous presentations.
• Current categorical approaches struggle to identify a single underlying cause for autism behaviors.
• The intricate and individualized nature of ASD may hinder the development of reliable biomarker tests.

Purpose of the Study:

• To explore network perspectives as a viable framework for understanding ASD.
• To critically evaluate the utility and potential harm of current biomarker tests for ASD.
• To identify promising biological pathways for future research in ASD.

Main Methods:

• Conceptual analysis of network theory applied to ASD.
• Review of existing literature on ASD etiology and biomarkers.
• Discussion of emergenic principles in developmental trajectories.
• Comparative analysis of ASD in single-gene versus nonsyndromic contexts.

Main Results:

• Network perspectives provide a robust framework for analyzing ASD's complexity.
• Existing biomarker tests for ASD are deemed potentially harmful and clinically unproven.
• The serotonin-melatonin-oxidative stress-placental pathway is highlighted as a key area for investigation.
• Emergenic principles suggest targeted interventions may have significant impact.

Conclusions:

• Network science offers a more effective lens for ASD research than categorical models.
• Caution is advised regarding the use of current ASD biomarker tests.
• Further research into the serotonin-melatonin-oxidative stress-placental axis is warranted for potential therapeutic targets.